A restriction fragment length polymorphism (RFLP) has been found in the gene for clotting factor VIII. Defects in this gene are the cause of hemophilia A. The DNA polymorphism affects an Xbal site in Intron 22 of the gene. Two alleles occur 1n a frequency of 59 and 41 percent of the X chromosomes tested. Furthermore, about 25 percent of females who are homozygous for the previously reported Bell RFLP in the factor VIII gene (1) are heterozygous for the Xbal polymorphism. This new RFLP thus represents a significant addition to available probes for the DNA-based prenatal diagnosis and carrier detection of this disease.
INTRODUCTION
Hemophilia A (classic hemophilia) is the most common severe inherited bleeding disorder, affecting at least one male in 10,000. The disease 1s caused by a deficiency of factor VIII, an essential protein cofactor in the intrinsic coagulation pathway. The gene for factor VIII is located at the distal end of the long arm of the human X-chromosome. Prenatal diagnosis of hemophilia is possible by fetal blood sampling, but this procedure is performed in the second trimester and carries about a 5 percent risk to the fetus. Carrier detection in women is often equivocal because of the wide range of clotting activity in normal and heterozygous females. Recently, the human factor VIII gene has been cloned and sequenced to completion, and recombinant DNA derived factor VIII has been obtained from transfected tissue culture cells (2,3). The availability of factor VIII DNA probes has led to the identification of several different mutations associated with hemophilia (4-6). A survey of the results supports the prediction that many unique mutations would be found to cause such an X-linked disease. This underscores the necessity of identifying restriction fragment length polymorphisms (RFLP) at this locus for use in DNA-based diagnosis. Such DNA polymorphisms can allow gene tracking in families at risk while remaining independent of the particular mutation causing hemophilia.
We initially reported a RFLP in the factor VIII gene involving a Bell site within Intron 18 of the gene, comprising a two allele system with frequencies of about 70 percent and 30 percent (1). The predicted frequency of "informative" females heterozygous for this polymorphism is ~42 percent. We demonstrated the applicability of this RFLP in a Southern blot carrier detection and in an antenatal diagnosis using DNA extracted by chorion villus biopsy at eight weeks of gestation (7). This RFLP marker is now in general use. Subsequently, a second RFLP in the factor VIII gene has been reported. A Bgll site flanking exon 28 (exact location unreported) is polymorphic, with a reported major allele frequency of from 74 to 94 percent 1n various populations (5). In combination, these two RFLPs are only informative for about 50-60 percent of females desiring counselling. Two non-factor VIII gene RFLPs, designated DX13 and Stl4, have been shown to be very tightly linked to the factor VIII locus and provide additional useful markers (1). In particular, Stl4 has many allelic forms and 1s almost always Informative for gene tracking. However, linked RFLP markers carry the risk of misdiagnosis due to recombination. Even though these two RFLPs are very tightly linked to the hemophilia A locus, there have been several recent reports of recombination between DX13 and factor VIII (8,9), and one report of a cross-over between Stl4 and the factor VIII gene (10). Hence there is a need to identify further RFLPs within the factor VIII gene itself.
MATERIALS AND METHODS

DNA Preparations and Hybridizations
DNA was prepared from human blood samples as described in (11). Electrophoresis in agarose gels and transfer to nitrocellulose followed standard procedures (12). Probes were gel isolated and labelled with [a-32 P]dCTP by calf thymus DNA priming (13) and hybridized in 50 percent formamide, 5xSSC, 50 mM sodium phosphate, 5x Denhardt's solution, 200 yg/ml denatured salmon sperm DNA and 10 percent dextran sulfate at 42*C overnight and washed at 67"C in 0.2xSSC, 0.1 percent SDS before exposure to X-ray film at -70*C with an intensifying screen (12). Factor VIII Probes and Gene Mapping Mapping of restriction sites surrounding the polymorphic Xbal site was performed on human factor VIII genomic clones and subclones described 1n (14) . Mapping was performed by standard procedures with single and double restriction enzyme digests. All map coordinates shown here refer to the coordinates of the factor VIII gene map given in (14) . DNA probes were gel isolated and subcloned into appropriate vectors (12) after they were identified as being free of highly repetitious DNA sequences by Southern blot hybridization with labeled, total human genomic DNA.
RESULTS AND DISCUSSION An Xbal Polymorphism in the Factor VIII Gene
In a screen of factor VIII gene intron and 3'-flanking sequence probes, we found that a 9.6 kb EcoRI fragment from intron 22 hybridized to two alternate Xbal fragments in Southern blots from five individuals. The variant JCba^I site was mapped to a location in the gene about 18 kb 3' to the previously reported polymorphic J3cU site. An apparent complication with this probe was its hybridization to a second location in the human genome. This was noted with several restriction enzymes. A telling example is the fact that the 9.6 kb E^oRI factor VIII genomic probe fragment hybridizes not only to a 9.6 kb EcoRI, but also to a 21 kb ^coRI fragment in genomic DNA isolated from all individuals tested (Fig. 1, lane 1 hybridization conditions (68* washes 1n 0.1X SSC) failed to eliminate this second site of hybridization. Several smaller subfragments of the original 9.6 kb probe still hybridized to this second region. In fact, these two regions are so homologous that several restriction sites are shared. Therefore, we found that double digestion with Xbal and Kpnl was helpful in moving the position of the hybridizing polymorphic factor VIII band away from the non-factor VIII band (see Fig. 1, lanes 2-5) . We recommend use of this double enzyme digestion procedure when using this polymorphic marker. In genomic digests with Xbal alone, probed with the 1.1 kb EcoRI/SstI fragment, the factor VIII alleles are 9.6 and 4.8 kb, while the homologous region fragment also migrates at 9.6 kb. Xbal plus Kpnl digests with the same probe yield factor VIII alleles of 6.2 and 4.8 kb, with a clearly separated 6.6 kb band from the non-factor VIII region. Alternatively, one can detect this RFLP with a probe located on the opposite side of the polymorphic ^bal site (Fig. 2, probe b) . A 1.6 kb j3stXI fragment probe will hybridize to allelic fragments of 6.2 or 1.4 kb in Xbal plus Kpnl digested DNA (see Fig. 3 ). Of course, either of these fragment probes detect the same Xbal site polymorphism and are suitable choices. Experience has indicated to us that probe b produces autoradiographs that are somewhat superior. The appearance of a second hybridizing region necessitated further characterization of the intron 22 region. Detailed restriction mapping of isolated factor VIII genomic clones, and the use of several probe fragments in the region of cloned and genomic DNA, contributed to the map shown in Fig. 2 and to • -affected male. 0 -female carrier (known before RFLP analysis). Consultands in each family whose carrier status was unknown before RFLP analysis are indicated as O . (The hybridizing band above the b2 allele 1s the 6.6 kb fragment from the non-factor VIII hybridizing region, and the 3.4 kb hybridizing band is from the factor VIII gene by reference to F1g. 2. Individual 3 in family B 1s also missing the 6.6 kb, non-factor VIII fragment.) region revealed hybridizing fragments consistent with that map and with the assignment of the DNA sequence polymorphism at that location. Further confirmation was acquired by Southern blot analysis of DNA known to be deleted in this portion of the factor VIII gene. We had previously reported that the X chromosome of the severe hemophiliac "H96" contains a 39 kb partial gene deletion extending from the 5' end of exon 22 Into exon 25 (4). In particular, the region containing the polymorphic Xbal site and the probes used in the current study are within this deletion. Lane 6 in Fig. 1 shows that neither the allelic 6.2 nor 4.8 kb Xbal/Kpnl fragments are present 1n the DNA from this Individual, while the 6.6 kb "non-factor VIII" fragment remains visible as expected.
The genetic location of the second hybridizing region remains unknown. It does not seem to He elsewhere in the factor VIII gene, since the sizes of the "second region" hybridizing bands in genomic Southern blot experiments (Fig. 1 and other data not shown) are Incompatible with the map of restriction sites 1n the factor VIII gene. In addition, all of the genomic clones spanning the factor VIII gene failed to hybridize with the 9.6 kb EcoRI probe, with the exception of those containing this very region of intron 22.
Frequency and Linkage of the Xbal Polymorphism
In order for this Xbal RFLP to be a useful adjunct to existing markers, the two alleles should occur 1n rather even frequencies in the population and should not segregate in a fixed relationship to the existing RFLP. The data summarized 1n the tables show that this is the case. In data from 88 chromosomes from a mixed population of non-hemoph1lic visitors to a Northern California hospital, the small Xbal allele occurred in 52 chromosomes (59 percent) and the large allele 1n 36 chromosomes (41 percent). This predicts that about 48 percent of females seeking counselling will be heterozygous for the marker. Furthermore, Table 2 shows that the Xbal RFLP can be useful 1n cases in which the Bell polymorphism 1s not. The small Bell allele (a^) was found to be associated with either Xbal allele bj or b 2 -Of the four possible haplotypes, no examples were found of the a^b-, combination-large Bel I plus small Xbal. It 1s not surprising to find some degree of linkage disequilibrium between two such close markers, and it is often the case that one of the four possible haplotypes will not be found in a survey of this size. The two polymorphic restriction sites He 18 kb apart, which roughly corresponds to a predicted recombination frequency of only 0.0OO2. The tabulated data suggest that the base change(s) producing the bj allele (creation of an Xbal site) occurred 1n the chromosomal context of the a^ allele (presence of the polymorphic Bell site) recently compared to the time required for recombination to randomize these two close markers. Despite the degree of linkage disequilibrium between these two factor VIII RFLPs, the tables show that there will be families which are homozygous for the Bc_U allele a, but heterozygous (informative) for the Xbal RFLP (such an example will be shown below). On the basis of Table 2 In family B, individual 2 can be diagnosed as a carrier on the basis of this RFLP. She too is heterozygous for the Xbal alleles (but was homozygous for the Bell polymorphism). The males in the family indicate that Xbal allele b^ associates with the normal factor VIII gene and allele b£ with the hemophilic gene. Since the consultands in both families are heterozygous for the Xbal RFLP, they would be candidates for prenatal diagnosis using this probe.
We have examined several other families (data not shown) which demonstrate Mendelian inheritance of the Xbal alleles in non-hemophilic families and which demonstrate consistent predictions in families informative for both this and the Bell RFLP. This newly reported restriction fragment length polymorphism in the factor VIII gene should be a useful addition to the available markers to increase the applicability and confidence of DNA based carrier detection and antenatal diagnosis of hemophilia A.
